LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Radicicol | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1705 | 4660 | 0.3654 | 0.1808 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1539 | 4405 | 0.3504 | 0.1274 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1004 | 4660 | 0.2151 | -0.1047 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1180 | 4405 | 0.2688 | -0.0255 |
MDA-MB-231 | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 1235 | 916 | 4660 | 0.1965 | -0.1459 |
MDA-MB-231 | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1072 | 4405 | 0.2440 | -0.0746 |
MDA-MB-231 | Radicicol | 10 | uM | LJP5 | 72 | hr | 1235 | 971 | 4660 | 0.2079 | -0.1220 |
MDA-MB-231 | Radicicol | 10 | uM | LJP6 | 72 | hr | 1235 | 833 | 4405 | 0.1887 | -0.1957 |
MDA-MB-231 | Withaferin A | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4860 | 4660 | 1.0433 | 1.0452 |
MDA-MB-231 | Withaferin A | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4613 | 4405 | 1.0473 | 1.0511 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4923 | 4660 | 1.0567 | 1.0588 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4250 | 4405 | 0.9646 | 0.9609 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2841 | 4660 | 0.6068 | 0.5360 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2493 | 4405 | 0.5654 | 0.4641 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1003 | 4660 | 0.2145 | -0.1065 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 72 | hr | 1235 | 978 | 4405 | 0.2229 | -0.1209 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 1235 | 858 | 4660 | 0.1843 | -0.1743 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 1235 | 898 | 4405 | 0.2049 | -0.1630 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP5 | 72 | hr | 1235 | 604 | 4660 | 0.1297 | -0.3127 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP6 | 72 | hr | 1235 | 593 | 4405 | 0.1350 | -0.3330 |
BT-20 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3909 | 3846 | 1.0169 | 1.0188 |
BT-20 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3839 | 3846 | 0.9988 | 0.9980 |
BT-20 | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3440 | 3846 | 0.8945 | 0.8805 |
BT-20 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3081 | 3846 | 0.8022 | 0.7706 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2834 | 3846 | 0.7370 | 0.6889 |